Schaper Benz & Wise Investment Counsel Inc Viatris Inc Transaction History

Schaper Benz & Wise Investment Counsel Inc

$1.16 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $156,314 - $194,639	-12,052 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$13.59 - $18.54 $52,702 - $71,898	-3,878 Reduced 24.34%	12,052 $168,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $227,799 - $298,528	15,930 New	15,930 $299,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

Vanguard Group Inc Valley Forge, PA

142M
Shares

$1.5 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

93.3M
Shares

$990 Million
0.03% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$666 Million
0.03% of portfolio
Price T Rowe Associates Inc Baltimore, MD

57.9M
Shares

$614 Million
0.08% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

57.5M
Shares

$610 Million
3.85% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Account